Saudi Journal of Ophthalmology · 2016 · 12 citations · 18 references
MedicineOphthalmologySurgeryOcular PathologyOphthalmic SurgeryVascular SurgeryRetinal SurgeryRetinal Vascular DiseaseVitreoretinal SurgeryAnti-vegf Ocular TherapyChoroidal HemorrhageDisplacementMacular NeovascularizationNatural Gas InjectionSecondary HemorrhageSubmacular HemorrhageVisual Function Loss
PURPOSE: = 3). METHODS: This is a retrospective case series study of 12 eyes from 12 patients in Aberdeen Royal Infirmary, Aberdeen, UK. The mean duration of visual loss was 10.8 ± 4.11 days. All cases received intravitreal injection of expansile gas within 24 h of presentation (C3F8 in 11 cases and SF6 in one case) and postured face down for five days. Anterior chamber paracentesis was done right after gas injection. Intravitreal anti-VEGF was injected at the same time in cases with CNV. Further anti-VEGF injections were done in CNV cases as needed afterwards. Cases were followed up for 6 months. RESULTS: The submacular hemorrhage was successfully displaced from underneath the fovea in all but one case. The bleeding disappeared totally in 44% of cases and was inferiorly displaced in 56%. VA improvement at 6 months was statistically significantly higher than baseline VA. All cases but 2 (one because of subfoveal fibrosis and one because of late presentation) experienced improved VA. The mean VA improved from 1.37 ± 0.18 logMAR at baseline to 0.83 ± 0.26 logMAR at 6 months. No complication related to the procedure was reported. CONCLUSION: Pneumatic displacement of submacular hemorrhage appears to be a safe and effective technique to treat the condition. It is an easy procedure that can be done in outpatient setting. Further studies are needed to validate our results.
18
Natural History of Macular Subretinal Hemorrhage in Age-Related Macular Degeneration
Andrea Scupola, G. Coscas, G. Soubrane et al. · Ophthalmologica · 1999 · 255 citations